EDITOR’S NOTE:
The project records appearing every week in the Site Selection Project Bulletin are pulled from the
Conway Projects Database, a proprietary resource with tens of thousands of records
of corporate end-user facility investments across all industry sectors and all world
geographies. Want to look for our projects yourself? Look
here.
New Models Head South
Stellantis plans to introduce two new models to the South American market, housing production at its Fiat brand manufacturing plant in Córdoba, Argentina.
Photo courtesy of Stellantis
As part of a $6.2 billion strategy to grow capabilities in South America, automaker Stellantis has announced new investment in Argentina. The $385 million project lands at the company’s Córdoba facility, located in the central Córdoba province. From 2025 to 2028, Stellantis will prepare to welcome two new undisclosed models to its Argentina productions site, which currently manufactures Stellantis’ Cronos model. The acquisition of Argentina-based auto parts company Sudamericana by the company will supply the plant with necessary parts as these operations reach full capacity.
ADVERTISEMENT
Modernized Medicine in Ireland
Eli Lilly and Company has completed its expansion in Kinsale, Ireland, and boosted investment in Limerick.
Photo courtesy of Eli Lilly and Company
Last week, Eli Lilly and Company announced a $1.8 billion investment across its sites in Limerick and Kinsale, Ireland. The news builds upon the company’s previously announced investment in March 2023 into its Limerick manufacturing facility, bringing total investment to $2 billion. The expansion supports production of biologic active ingredients which will largely support Eli Lilly’s Alzheimer’s disease portfolio. The project will introduce advanced technology, including AI and automated robots. The facility is expected to be complete in 2026, creating 150 new jobs. Meanwhile, the company announced the $800 million expansion of the Kinsale facility is now complete. This site focused on expanding production of obesity and diabetes medication, featuring a new manufacturing platform catering to developing complex peptides.
ADVERTISEMENT
Jabil Returns to India
Last week, Jabil and the Tamil Nadu state government signed a Memorandum of Understanding for a new manufacturing plant in the city of Tiruchirappalli.
Getty Images
An estimated 5,000 jobs are on the way to the southern India city of Tiruchirappalli, located in the state of Tamil Nadu, thanks to a fresh $241 million electronic components manufacturing facility investment from Jabil. The company has said the plant will produce parts for a number of customers including Apple, Nokia and HP. Jabil’s project builds upon the region’s industry success, which provided a strategic pull for the company to expand its global portfolio. “India is emerging as a key manufacturing hub,” said Jabil Global Business Units Executive Vice President Matt Crowley. “Our expansion in India will enable Jabil to meet and grow with the future needs of our customers and complement our existing facility in Pune, Maharashtra, in operation since 2003.”
Reports compiled and written by Alexis Elmore, edited by Adam Bruns
